Manipal Health Enterprises IPO GMP & Allotment
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.
- IPO Price Band
- ₹560.00 - ₹590.00
- Lot Size
- 25 Shares
- Bidding Closes
- 31 Jul 2026
- Listing Date
- 05 Aug 2026
Complete IPO information
| IPO Open Date | 29 Jul 2026 |
|---|---|
| IPO Close Date | 31 Jul 2026 |
| IPO Price Band | ₹560.00 - ₹590.00 |
| Lot Size | 25 Shares |
| Current GMP | ₹6 |
| Estimated Listing Gain | +1.02% |
| Issue Size | - |
| Fresh Issue | - |
| Issue Type | Mainboard |
| IPO Listing | NSE, BSE |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | 4.92x |
| Minimum Investment | ₹14,750 |
| DRHP Draft Prospectus | - |
| RHP Draft Prospectus | - |
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Manipal Health Enterprises is priced at ₹590 per share. With a minimum lot size of 25 shares, a retail investor applying for one lot would need approximately ₹14,750 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Manipal Health Enterprises stands at ₹6, implying an estimated listing gain of around 1.02% over the issue price if it holds until listing. This is down ₹4 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Manipal Health Enterprises's IPO was subscribed 4.92x overall, with a category-wise breakdown of Retail 0.93x, QIB 8.25x.
Among the strengths highlighted in Manipal Health Enterprises's IPO documents: A large network of multi-speciality hospitals supported by a wide base of doctors.; Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue..
Investors should also weigh the risk factors Manipal Health Enterprises has disclosed, including: High dependence on insurance and third-party administrators for revenue..
A share of Manipal Health Enterprises's issue proceeds is earmarked for Repayment Of Borrowings: 5378 (67.23%).
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
IPO roadmap at a glance
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 31 Jul 2026 | ₹6.00 | -₹4.00 | 1.02% |
| 30 Jul 2026 | ₹10.00 | - | 1.69% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 25 | ₹14,750 |
| Retail Maximum | 13 Lot | 325 | ₹1,91,750 |
| S-HNI Minimum | 14 Lot | 350 | ₹2,06,500 |
| S-HNI Maximum | 67 Lot | 1,675 | ₹9,88,250 |
| B-HNI Minimum | 68 Lot | 1,700 | ₹10,03,000 |
Objects of the Issue & Official Documents
- Repayment Of Borrowings 5378 (67.23%)
- General Corporate Purpose 2048 (25.59%)
Important takeaways before applying
Strengths
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Risks
- High dependence on insurance and third-party administrators for revenue.
- Delays in payments from government schemes can impact cash flows.
- Expansion into new regions may face operational and market challenges.
- Failure to attract sufficient patients can lead to underutilised capacity.
- High outstanding receivables may affect working capital and liquidity.
Manipal Health IPO Reservation
The Manipal Health IPO follows the SEBI-prescribed allocation structure for a Book Build Issue. The issue is divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Anchor Investors. This allocation framework is designed to ensure broad participation from institutional as well as retail investors.
The category-wise reservation below shows the percentage of shares reserved for each investor segment. The final allotment in every category will depend on the subscription received and the basis of allotment approved after the IPO closes.
| Investor Category | Shares Offered | Reservation (%) |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 75% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 10% |
Manipal Health IPO Anchor Investors
Manipal Health Limited has scheduled the Anchor Investor Bidding on July 28, 2026, one working day before the IPO opens for public subscription. The anchor book is reserved for Qualified Institutional Buyers (QIBs) and is intended to gauge institutional demand ahead of the public issue.
The company will announce the names of participating anchor investors, the total anchor allocation, and the issue size after the completion of the anchor bidding process. The allotted anchor shares will remain subject to the applicable SEBI lock-in requirements.
| Particular | Details |
|---|---|
| Anchor Bidding Date | July 28, 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Issue Size | [.] Cr. |
| Lock-in Period End Date (50% Shares – 30 Days) | 2026 |
| Lock-in Period End Date (Remaining 50% Shares – 90 Days) | 2026 |
Manipal Health Enterprises IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 29 Jul 2026 |
| IPO Close Date | 31 Jul 2026 |
| Basis of Allotment | 03 Aug 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 05 Aug 2026 |
Note: The timeline for Manipal Health Enterprises IPO is tentative and subject to change.
Manipal Health IPO Promoters and Holding Pattern
Manipal Health Enterprises Limited is promoted by Dr. Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd., Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd.. The promoter group has played a significant role in establishing and expanding one of India's leading multi-specialty healthcare and hospital networks.
Following the completion of the IPO, the promoters will continue to hold a substantial stake in the company. However, the final post-issue promoter shareholding percentage will be confirmed after the completion of the IPO process and the allotment of shares.
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 1,17,97,57,321 | 81.43% |
| Promoter Holding Post Issue | 1,31,53,50,541 | -% |
Manipal Health Enterprises Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Manipal Health About IPO
Manipal Health Enterprises Limited is a healthcare company in India that runs many hospitals, clinics, and diagnostic centres. It is part of the Manipal Group, which was started by T. M. A. Pai.
Moreover, the company provides different types of medical services such as organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare.
The company has a major of give good quality care to patients and make healthcare more available. As of September 30, 2025, the company runs 38 hospitals (or 48 hospitals on a pro forma basis) with 10,761 beds (or 12,367 licensed beds on a pro forma basis). It also operates 17 clinics.
Manipal Health Enterprises Company Financials
To Be Updated Soon
Manipal Health Enterprises Company Valuation – FY2026
To Be Updated Soon
Manipal Health Enterprises IPO Peer Group Comparison
To Be Updated Soon
IPO Lead Managers aka Merchant Bankers
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- Goldman Sachs (India) Securities Private Limited
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
- UBS Securities India Private Limited
- DBS Bank India Limited
Compare Manipal Health Enterprises IPO with similar IPOs
Manipal Health Enterprises IPO FAQs
Comments
Share a useful question or insight about Manipal Health Enterprises.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...